ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecules and Cells

• Publication date

  2010-04-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molcel.2010.02.020PMID 20385094PMCID PMC2854677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lumen formation during mammary epithelial morphogenesis: insights from in vitro and in vivo models

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• The RSK family of kinases: emerging roles in cellular signalling

  2008cited by this paper
• Substrate Discrimination among Mitogen-activated Protein Kinases through Distinct Docking Sequence Motifs*

  2008cited by this paper
• Single and Combined Silencing of ERK1 and ERK2 Reveals Their Positive Contribution to Growth Signaling Depending on Their Expression Levels

  2007influential reference
• Molecular definition of breast tumor heterogeneity.

  2007cited by this paper
• Differential mRNA distribution of components of the ERK/MAPK signalling cascade in the adult mouse brain

  2007cited by this paper
• FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts.

  2006cited by this paper
• ERK2 is required for efficient terminal differentiation of skeletal myoblasts.

  2006cited by this paper
• H-Ras, R-Ras, and TC21 differentially regulate ureteric bud cell branching morphogenesis.

  2006cited by this paper
• Purification and unique properties of mammary epithelial stem cells

  2006cited by this paper
• MAPK signal specificity: the right place at the right time.

  2006cited by this paper
• ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially

  2006cited by this paper
• Fra-1 a target for cancer prevention or intervention.

  2006cited by this paper
• Modelling glandular epithelial cancers in three-dimensional cultures

  2005influential reference
• Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition

  2005cited by this paper
• Regulatory phosphorylation of Bim: sorting out the ERK from the JNK

  2005influential reference
• Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo.

  2005influential reference
• β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition

  2004cited by this paper
• Epithelial-mesenchymal transitions: twist in development and metastasis.

  2004cited by this paper
• ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions

  2004cited by this paper
• A Network of Immediate Early Gene Products Propagates Subtle Differences in Mitogen-Activated Protein Kinase Signal Amplitude and Duration

  2004influential reference
• Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry.

  2004cited by this paper
• beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.

  2004cited by this paper
• Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis

  2003influential reference
• An essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development

  2003cited by this paper
• Phosphorylation of p90 Ribosomal S6 Kinase (RSK) Regulates Extracellular Signal-Regulated Kinase Docking and RSK Activity

  2003cited by this paper
• Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

  2003cited by this paper
• Essential role for ERK2 mitogen‐activated protein kinase in placental development

  2003cited by this paper
• Epithelial-mesenchymal transitions in development and pathologies.

  2003cited by this paper
• Accumulation of Fra-1 in ras-Transformed Cells Depends on Both Transcriptional Autoregulation and MEK-Dependent Posttranslational Stabilization

  2003cited by this paper
• Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation

  2003cited by this paper
• Targeting RAS signalling pathways in cancer therapy

  2003influential reference
• Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.

  2002cited by this paper
• Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis

  2002cited by this paper
• Molecular interpretation of ERK signal duration by immediate early gene products

  2002cited by this paper
• The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini.

  2002cited by this paper
• Transactivation of Fra-1 and Consequent Activation of AP-1 Occur Extracellular Signal-Regulated Kinase Dependently

  2002cited by this paper
• Docking Sites on Substrate Proteins Direct Extracellular Signal-regulated Kinase to Phosphorylate Specific Residues*

  2001cited by this paper
• A genome-wide survey of RAS transformation targets

  2000cited by this paper
• A conserved docking motif in MAP kinases common to substrates, activators and regulators

  2000cited by this paper
• Dimerization in MAP-kinase signaling.

  2000cited by this paper
• Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

  1999cited by this paper
• Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.

  1999cited by this paper
• The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk‐1 phosphorylation from MAP kinase activation

  1998cited by this paper
• Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts.

  1997cited by this paper
• Early role of Fsp1 in epithelial-mesenchymal transformation.

  1997cited by this paper
• Early role of Fsp1 in epithelial-mesenchymal transformation.

  1997cited by this paper
• p42 mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation

  1994cited by this paper
• ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF.

  1991cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990influential reference

• The small Rho GTPase Rif promotes cancer progression through ERK2-mediated epithelial-mesenchymal transition

  2026cites this paper
• Serotonin promotes aggressive features in breast cancer cells by modulating proliferation and migration, hormone receptors and HER2 expression.

  2025cites this paper
• BRAF inhibition increases TGFβ2 production and stimulates metastasis in mice with endogenous BRAFV600E-induced hepatocellular carcinoma.

  2025cites this paper
• Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition

  2025cites this paper
• The Diatom Odontella aurita Modulates Melanogenesis in B16-F0 Cell Line

  2025cites this paper
• Noncoding RNAs as regulators of FOSL1 in cancer

  2025cites this paper
• Loss of E‐cadherin Activates EGFR‐MEK/ERK Signaling, Promoting Cervical Cancer Progression

  2025cites this paper
• Mechanism of ERK-mediated Rho Activation and Stress Fiber Assembly for Cell Migration

  2025cites this paper
• Cancer hotspot mutations rewire ERK2 specificity by selective exclusion of docking interactions

  2025cites this paper
• Integrated methylome analysis identifies an epigenetically silenced tumor suppressor RASA4 in small cell lung cancer

  2025cites this paper
• ERK2-mediated phosphorylation of ZEB1 at S322 enhances PD-L1 expression and EMT, leading to pancreatic cancer progression

  2025cites this paper
• Lysosome-dependent nutrient scavenging underlies stress adaptation during epithelial-to-mesenchymal transition

  2025cites this paper
• Context-dependent roles for ubiquitous mitochondrial creatine kinase CKMT1 in breast cancer progression.

  2024cites this paper
• Overexpression of Nogo-A changes nerve growth factor signaling dynamics in PC12 cells.

  2024cites this paper
• MicroRNA-145-5p inhibits the tumorigenesis of breast cancer through SENP2-regulated ubiquitination of ERK2

  2024cites this paper
• Methods and computational tools to study eukaryotic cell migration in vitro

  2024cites this paper
• Progress in the development of ERK1/2 inhibitors for treating cancer and other diseases.

  2024cites this paper
• Depletion of calpain2 accelerates epithelial barrier establishment and reduces growth factor-induced cell scattering.

  2024cites this paper
• The strategic involvement of IRS in cancer progression.

  2023cites this paper
• Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates

  2023cites this paper
• Navigating the ERK1/2 MAPK Cascade

  2023cites this paper
• Identification and biochemical characterization of small molecule inhibitors of ERK2 that target the D-recruitment site.

  2023cites this paper
• The potential of activator protein 1 (AP-1) in cancer targeted therapy

  2023cites this paper
• The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas

  2023cites this paper
• Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer

  2023cites this paper
• The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer

  2023cites this paper
• Chronic Inhalation Exposure to Antimony Trioxide Exacerbates the MAPK Signaling in Alveolar Bronchiolar Carcinomas in B6C3F1/N Mice

  2023cites this paper
• FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer

  2023cites this paper
• The integration of Tgfβ and Egfr signaling programs confers the ability to lead heterogeneous collective invasion

  2023cites this paper
• PTEN: a novel target for vitamin D in melanoma.

  2022cites this paper
• Prenatal maternal stress promotes neural stem cell proliferation in the ependymal-subventricular zone of adult male offspring

  2022cites this paper
• Metabolite activation of tumorigenic signaling pathways in the tumor microenvironment

  2022cites this paper
• ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transition

  2022cites this paper
• ERK2 signaling regulates cell-cell adhesion of epithelial cells and enhances growth factor-induced cell scattering.

  2022cites this paper
• ERK signaling for cell migration and invasion

  2022cites this paper
• Sprouty and Spred temporally regulate ERK1/2-signaling to suppress TGFβ-induced lens EMT.

  2022cites this paper
• The ERK2 DBP domain opposes pathogenesis of a JAK2V617F-driven myeloproliferative neoplasm.

  2022cites this paper
• Altered propionate metabolism contributes to tumor progression and aggressiveness

  2022cites this paper
• The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting

  2022cites this paper
• Overexpression of dual-specificity phosphatases 4 and 13 attenuates transforming growth factor β1-induced migration and drug resistance in A549 cells in vitro.

  2022cites this paper
• Immunohistochemical expressions of EMT markers in pan-RAS–pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients

  2022cites this paper
• RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell Proliferation

  2021cites this paper
• A Systematic Review of Lymphangioleiomyomatosis on Diagnosis and Molecular Mechanism

  2021cites this paper
• Alternative Splicing of MAPKs in the Regulation of Signaling Specificity

  2021cites this paper
• The RhoA dependent anti-metastatic function of RKIP in breast cancer

  2021cites this paper
• KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition

  2021influential citation
• Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer

  2021cites this paper
• Fra-1 regulates its target genes via binding to remote enhancers without exerting major control on chromatin architecture in triple negative breast cancers

  2021cites this paper
• Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role.

  2021cites this paper
• Effects of bisphenol A on the proliferation, migration, and tumor growth of colon cancer cells: In vitro and in vivo evaluation with mechanistic insights related to ERK and 5-HT3.

  2021cites this paper
• Dynamic EMT: a multi‐tool for tumor progression

  2021cites this paper
• Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer

  2020cites this paper
• LB968 Inhibition of sonic hedgehog signalling via MAPK activation controls chemotherapy-induced alopecia

  2020cites this paper
• Cell Signaling in Hepatocellular Carcinoma

  2020cites this paper
• The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications’ door

  2020cites this paper
• Age-induced methylmalonic acid accumulation promotes tumor progression and aggressiveness

  2020cites this paper
• Inhibition of sonic hedgehog signaling via MAPK activation controls chemotherapy-induced alopecia.

  2020cites this paper
• Age-induced accumulation of methylmalonic acid promotes tumour progression

  2020cites this paper
• Genome‐wide cooperation of EMT transcription factor ZEB1 with YAP and AP‐1 in breast cancer

  2020cites this paper
• Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitor in triple-negative breast cancer cell line.

  2020cites this paper
• L1CAM is involved in lymph node metastasis via ERK1/2 signaling in colorectal cancer.

  2020cites this paper
• Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases—Current State of the Art

  2020cites this paper
• Integrin β1D Deficiency–Mediated RyR2 Dysfunction Contributes to Catecholamine-Sensitive Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy

  2020cites this paper
• microRNA-431 promotes metastasis of pancreatic neuroendocrine tumors by targeting DAB2IP, a RasGAP tumor suppressor.

  2020cites this paper
• Age-induced accumulation of methylmalonic acid promotes tumour progression

  2020cites this paper
• Molecular Carcinogenesis

  2020cites this paper
• Enhancement of leukemia‐like phenotypes in Drosophila mxc mutant larvae due to activation of the RAS‐MAP kinase cascade possibly via down‐regulation of DE‐cadherin

  2020influential citation
• Interleukin-1β promotes interleulin-6 expression via ERK1/2 signaling pathway in canine dermal fibroblasts

  2019cites this paper
• Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies

  2019cites this paper
• EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer.

  2019cites this paper
• Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer

  2019cites this paper
• Resistance to ERK 1 / 2 pathway inhibitors ; sweet spots , fitness deficits and drug addiction

  2019cites this paper
• YDJC Induces Epithelial-Mesenchymal Transition via Escaping from Interaction with CDC16 through Ubiquitination of PP2A

  2019cites this paper
• Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2

  2019cites this paper
• MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAFV600E amplification whereas KRASG13D amplification promotes EMT-chemoresistance

  2019cites this paper
• Biological Rationale for Targeting MEK/ERK Pathways in Anti-Cancer Therapy and to Potentiate Tumour Responses to Radiation

  2019cites this paper
• Non-redundant functions of EMT transcription factors

  2019cites this paper
• NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer

  2019cites this paper
• The role of proteases in epithelial-to-mesenchymal cell transitions in cancer

  2019cites this paper
• Resistance to ERK1/2 pathway inhibitors; sweet spots, fitness deficits and drug addiction

  2019cites this paper
• The Role of PI3K/Akt and ERK in Neurodegenerative Disorders

  2019cites this paper
• Glucocorticoid receptor–IRS-1 axis controls EMT and the metastasis of breast cancers

  2019cites this paper
• Dusp6 Inhibits Epithelial-mesenchymal Transition in Endometrial Adenocarcinoma Via ERK Signaling Pathway

  2019cites this paper
• ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation

  2019cites this paper
• Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis

  2019cites this paper
• Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2

  2019cites this paper
• GLS2 is protumorigenic in breast cancers

  2019cites this paper
• Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization.

  2019influential citation
• ERK1/ATF-2 signaling axis contributes to interleukin-1β-induced MMP-3 expression in dermal fibroblasts

  2019cites this paper
• EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers

  2018cites this paper
• TIP60-dependent acetylation of the SPZ1-TWIST complex promotes epithelial–mesenchymal transition and metastasis in liver cancer

  2018cites this paper
• Overexpression of GRB2 Enhances Epithelial to Mesenchymal Transition of A549 Cells by Upregulating SNAIL Expression

  2018cites this paper
• Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors.

  2018cites this paper
• RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact

  2018cites this paper
• Phenotype Relevant Network-based Biomarker Discovery Integrating Multiple Omics Data (EMT Network-based Lung Cancer Prognosis Prediction)

  2018cites this paper
• Protein kinase Cε regulates nuclear translocation of extracellular signal-regulated kinase, which contributes to bradykinin-induced cyclooxygenase-2 expression

  2018cites this paper
• MiR-22 suppresses epithelial–mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop

  2018cites this paper
• Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion

  2018cites this paper
• EGF-reduced Wnt 5 a transcription induces epithelial-mesenchymal transition via Arf 6-ERK signaling in gastric cancer cells

  2018cites this paper
• A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses.

  2018cites this paper